Determination of the Elimination Half-Life of Fibroblast Growth Factor-23-Reference-Cited by-同舟云学术

Determination of the Elimination Half-Life of Fibroblast Growth Factor-23

Published:2007-06-01 Issue:6 Volume:92 Page:2374-2377
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Khosravi Azarmindokht¹,Cutler Carolee M.¹,Kelly Marilyn H.¹,Chang Richard²,Royal Richard E.³,Sherry Richard M.³,Wodajo Felasfa M.⁴,Fedarko Neal S.⁵,Collins Michael T.¹

Affiliation:

1. Skeletal Clinical Studies Unit (A.K., C.M.C., M.H.K., M.T.C.), Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892

2. Department of Radiology (R.C.), Mark O. Hatfield Clinical Center, Bethesda, Maryland 20892

3. Surgery Branch (R.E.R., R.M.S.), National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892

4. Department of Orthopedics and Pediatrics (F.M.W.), Georgetown University, Washington, D.C.

5. Division of Geriatric Medicine and Gerontology (N.S.F.), Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/92/6/2374/10780658/jcem2374.pdf

Reference29 articles.

1. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.;Cai;N Engl J Med,1994

2. Tumor-induced osteomalacia: clinical and basic studies.;Shane;J Bone Miner Res,1997

3. Tumor-induced osteomalacia.;Jan de Beur;JAMA,2005

4. Tumor-induced osteomalacia and the regulation of phosphate homeostasis.;Kumar;Bone,2000

5. Tumor-induced osteomalacia.;Drezner;Rev Endocr Metab Disord,2001

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?;Pharmacology & Therapeutics;2024-07

2. Exploring endocrine FGFs - structures, functions and biomedical applications;International Journal of Biochemistry and Molecular Biology;2024

3. Phosphaturic Mesenchymal Tumors with or without Phosphate Metabolism Derangements;Current Oncology;2023-08-08

4. Tissue engineering in reconstructive urology—The current status and critical insights to set future directions-critical review;Frontiers in Bioengineering and Biotechnology;2023-03-01

5. Tumor-Induced Osteomalacia as a Result of a Phosphaturic Mesenchymal Tumor: Detecting Rare Origin;Applied Sciences;2023-01-13